News & Updates

Tacrolimus appears to be more effective than cyclosporine in improving patient and graft survival after liver transplantation (LT) for primary sclerosing cholangitis (PSC), results of a study have shown.

A retrospective, propensity score-matched analysis from Singapore demonstrates the feasibility of transanal total mesorectal excision with delayed coloanal anastomosis (TaTME-DCAA) as a surgical alternative for non-metastatic low rectal cancer.

The guanylate cyclase C agonist linaclotide helps increase the frequency of bowel movements in children with functional constipation, according to data from a phase III trial.

In advanced nonsmall cell lung cancer (NSCLC) patients with anorexia, treatment with mirtazapine leads to a substantial increase in energy intake despite having no effect on appetite, as shown in a study.

High-flow nasal cannula therapy (HFNT) is effective in reducing the intensity of the sensory and affective components of dyspnoea, independent of oxygen addition, suggests a study.

Oesophageal cancer survivors are more likely to develop late-onset pneumonia during their clinical course, a study suggests.

New drug applications approved by US FDA as of 01-15 January 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.